OlleveCare logo

OlleveCare Review

GLP-1 weight-loss telehealth · Independently scored 3.9/10

Best for: a published state list — 13 of 50 — when most of the register publishes none

3.9
★★☆☆☆2/5

OlleveCare falls below our bar on medical oversight. Read the breakdown below before you give it money.

Covered by the plan

Medication

Not stated

Clinician visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Booking has to begin before a price appears, and OlleveCare says nothing about its operating entity, its medical director or the pharmacy behind it. The storefront is small and started in virtual urgent care, adding a cash-pay weight-management track on compounded semaglutide and compounded tirzepatide; 13 states are listed, DC among them. Urgent care by video and refills of non-controlled drugs remain part of what it does.

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Price after intake13 statesNo FDA letter on recordVideo visit required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Vetted alternatives to OlleveCare

7.9/ 10
Verified partner

Oak

Best for: semaglutide at $119/month, 37% under the register median

★★★★4/5

Editorial score · methodology

$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →
6.5/ 10
Verified partner

Direct Meds

Best for: compounded semaglutide at $249/month

★★★☆☆3.3/5

Editorial score · methodology

$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
8.8/ 10
Verified partner

Found

Best for: tirzepatide at $169/month, 37% under the register median

★★★★4.4/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →
OlleveCare logo
2.0 / 5
Our editorial rating
Visit OlleveCare

OlleveCare at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Availability
13 states
FDA status
No FDA warning letter on record

How OlleveCare scores

Six columns, each one computed from something OlleveCare has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.

Value25%

3.0/10

No monthly price is published at all, so value cannot be measured against the register. Capped rather than scored.

Effectiveness25%

5.0/10

Publishes no medication list or price, so what is prescribed here cannot be established. Held at the midpoint — this is a gap in the record, not a finding about the drugs.

User Experience15%

2.5/10

On the seller's own pages, no price appears until the medical intake is finished; a live video visit is required, which is slower but is the more careful intake.

Trust & Safety15%

4.0/10

does not name a dispensing pharmacy; withholds price until after the intake; publishes its state list. Our verification confidence is low.

Accessibility10%

4.1/10

Publishes coverage in 13 of 50 states.

Support10%

5.0/10

No published price, so what a price would include cannot be assessed. Held at the midpoint.

6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →

What we checked on OlleveCare

Last checked June 2026
  • Checked state coverage: 13 states
  • Searched our FDA enforcement register for this operator

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: low.

What signing up with OlleveCare involves

Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.

  1. 1OlleveCare does not show a price until you have worked through its medical questionnaire. Budget for the fact that you cannot compare it against anything until you have handed over health information.
  2. 2The intake requires a live video visit with a clinician, which is more than most of the register asks and slower to complete.
  3. 3OlleveCare does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
Price shown only after intakeLive video visit required
  • No comparable monthly cash price for the medication is on record — either nothing is published, or what is published is a fee, an insured copay or a per-vial rate rather than a monthly cost.
  • Coverage is published for 13 of 50 states.

OlleveCare support, as documented

GLP-1 medications OlleveCare offers

Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.

In its favor

  • No FDA warning letter matched this operator when we searched our enforcement register
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Against it

  • No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
  • Coverage is published for 13 states only, so this may not reach you
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here

What OlleveCare charges

OlleveCare does not publish a standing monthly price. That is a choice, and it means you cannot compare it against anything until you have gone through an intake and been quoted. When you get that quote, ask specifically for the ongoing monthly figure and what it includes — not the first-month rate, and not a program total divided by its length.

What OlleveCare dispenses

OlleveCare prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them.

What we could verify

On the record: it operates in 13 states. We searched the federal warning-letter record for this operator and came back with nothing. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.

Who should look elsewhere

  • You want the FDA-approved pen specifically. Nothing here is the approved finished product.
  • You need to compare prices before committing time to an intake — there is no published figure to compare.
  • You need to bill insurance. Like most of this market, this is cash-pay.

Our read

We cannot tell you whether OlleveCare is priced well, because it does not say. That is not automatically disqualifying — plenty of legitimate operators quote after intake — but it does mean the comparison has to happen after you have spent the time, which is the wrong order for the buyer. CoreAge Rx is the nearest comparison we track, and worth reading alongside this.

The Bottom Line

OlleveCare falls below our bar on medical oversight. Read the breakdown below before you give it money.

Score: 3.9/10Best for: a published state list — 13 of 50 — when most of the register publishes none

Before you pay OlleveCare

Check today's price, then book the free consultation.

Where OlleveCare is the wrong choice

No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.

  • If you need the FDA-approved pen rather than a compounded vial, consider Found.
  • If you want a human checking in, not just a prescription, consider Oak.
  • If your state is outside the area this one covers, consider Direct Meds.

Frequently Asked Questions

Glossary

The words sellers use, defined. Tap any term.

Sources

Cited across this OlleveCare review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of August 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.

See OlleveCare's current pricing

The free consultation is where you learn whether you qualify, and what it costs today.